If you’ve stumbled using AI, take heart: you’re not alone. Here are some common issues to look out for, and how to correct course.
Brian Lian founded publicly traded Viking Therapeutics to focus on metabolic diseases. With obesity drugs in development and the GLP-1 space booming, it’s now a prime M&A target for giants jostling for their share of a potential $100 billion market.
As the new year approaches, recent and upcoming changes in the business environment will impact how small businesses operate. Here’s what leaders should pay attention to.